CARLO DENNIS J PHD 4/A
4/A · Adamis Pharmaceuticals Corp · Filed Mar 12, 2019
Insider Transaction Report
Form 4/AAmended
CARLO DENNIS J PHD
DirectorPresident/CEO10% Owner
Transactions
- Exercise/Conversion
Restricted Stock Units
2019-02-21−27,822→ 55,645 total→ Common Stock (27,822 underlying)
Footnotes (3)
- [F1]Represents the vesting of a portion of previously granted restricted stock units (RSU), with shares of common stock to be issued following vesting of the RSUs as described in the award agreement relating to the RSUs.
- [F2]This Form 4A is filed to reflect on column 5 of Table II as a disposition, rather than as an acquisition as reflected on the reporting person's Form 4 originally filed February 25, 2019, the vesting of a portion of the restricted stock unit originally granted to the reporting person.
- [F3]On February 21, 2018, the reporting person was granted 83,467 restricted stock units. 1/3 of the Restricted Stock Units vest on each anniversary of the grant date over a three year period provided that the Reporting Person has continued to provide services to the Company during such period.